✦ LIBER ✦

Use of isoflavone supplements is associated with reduced postmenopausal breast cancer risk

✍ Scribed by Beatrice A. Boucher; Michelle Cotterchio; Laura N. Anderson; Nancy Kreiger; Victoria A. Kirsh; Lilian U. Thompson

Book ID: 115556546
Publisher: John Wiley and Sons
Year: 2012
Tongue: French
Weight: 206 KB
Volume: 132
Category: Article
ISSN: 0020-7136
DOI: 10.1002/ijc.27769

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Birth weight is associated with postmeno

Birth weight is associated with postmenopausal breast cancer risk in Swedish women

✍ Lahmann, P H; Gullberg, B; Olsson, H; Boeing, H; Berglund, G; Lissner, L 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 75 KB

Long-Term Metformin Use Is Associated Wi

Long-Term Metformin Use Is Associated With Decreased Risk of Breast Cancer

✍ Bodmer, M.; Meier, C.; Krahenbuhl, S.; Jick, S. S.; Meier, C. R. 📂 Article 📅 2010 🏛 American Diabetes Association 🌐 English ⚖ 76 KB

Overall, Postmenopausal Use of Combined

Overall, Postmenopausal Use of Combined Hormones Is Not Associated with Increased Risk of Cervical Cancer

✍ D. Hollander 📂 Article 📅 2007 🏛 Guttmacher Institute 🌐 English ⚖ 35 KB

Statin use was not associated with a red

Statin use was not associated with a reduced risk of fracture in postmenopausal women

📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Reducing the risk of bone loss associate

Reducing the risk of bone loss associated with breast cancer treatment

✍ P. Hadji 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 207 KB

Smoking is associated with postmenopausa

Smoking is associated with postmenopausal breast cancer in women with high levels of estrogens

✍ Jonas Manjer; Robert Johansson; Per Lenner 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 72 KB 👁 2 views

## Abstract We investigated the association between smoking and risk of postmenopausal breast cancer in groups defined by high levels of estrogens, a factor known to enhance tumour progression. Two prospective cohorts of Swedish women provided 260 postmenopausal breast cancer cases and 514 controls